Arcutis Biotherapeutics Inc 's ability to collect accounts receivable sequentially worsen to 3.3, indicating more challenging environment then in the second quarter 2026, but still, it is a far cry from any concerns. Arcutis Biotherapeutics Inc 's Accounts Receivable average collection period in the Sep 30 2026 quarter, has increased to 111 days, from 110 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 90 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 643 to 877.

What is Receivable Turnover Ratio?
What is Arcutis Biotherapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ARQT Receivables Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Receivable Change	48.79 %	45.44 %	69.03 %	100.13 %	91.48 %
Y / Y Revenue Change	45.05 %	59.33 %	60.07 %	81.48 %	121.69 %
Receivable Turnover Ratio (TTM)	3.3	3.31	3.24	3.32	3.34
ARQT's Total Ranking	# 877	# 643	# 2404	# 744	#
Accounts Receivable average collection period days	111	110	112	110	109
Seq. Receivable Change	10.39 %	7.47 %	-1.27 %	27.03 %	7.9 %
Seq. Revenue Change	10.83 %	23.21 %	-18.61 %	30.52 %	21.74 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 19
Healthcare Sector	# 91
Overall Market	# 877

Receivable Turnover Ratio Statistics
High	Average	Low
1.06	0.54	0.03
(Jun 30 2026)		(Jun 30 2023)

ARQT Company Profile • Back to ARQT Efficiency Comparisons • Compare ARQT Receivables Turnover Ratio to its Competitors

Financial Statements
Arcutis Biotherapeutics Inc 's Accounts Receivable	$ 171 Millions	Visit ARQT's Balance sheet
Arcutis Biotherapeutics Inc 's Sales TTM	$ 509 Millions	Visit ARQT's Income Statement
Sources of ARQT's Revenues		Visit ARQT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ARQT's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ARQT's Growth Rates	ARQT's Roa	ARQT's Inventory Turnover Ratio	ARQT's Dividend Comparisons
ARQT's Profitability Ratios	ARQT's Roi	ARQT's Asset Turnover Ratio	ARQT's Dividend Growth
ARQT's Valuation Ratios	ARQT's Roe	ARQT's Financial Strength Ratios	ARQT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
Inspire Medical Systems inc	8.15	$ 882.194 Millions	$ 108.207 Millions
Adapthealth Corp	8.14	$ 3,152.043 Millions	$ 387.280 Millions
Rhythm Pharmaceuticals Inc	8.03	$ 280.748 Millions	$ 34.950 Millions
Alphatec Holdings Inc	7.91	$ 839.652 Millions	$ 106.153 Millions
Exelixis Inc	7.89	$ 2,496.861 Millions	$ 316.636 Millions
Henry Schein Inc	7.84	$ 13,734.000 Millions	$ 1,752.000 Millions
Idexx Laboratories Inc	7.78	$ 4,663.675 Millions	$ 599.701 Millions
Madrigal Pharmaceuticals Inc	7.70	$ 1,427.940 Millions	$ 185.380 Millions
Pulmonx Corporation	7.56	$ 89.176 Millions	$ 11.791 Millions
Merit Medical Systems Inc	7.53	$ 1,612.236 Millions	$ 214.065 Millions
Cerus Corporation	7.48	$ 226.798 Millions	$ 30.308 Millions
Insmed Inc	7.45	$ 1,479.040 Millions	$ 198.502 Millions
Novocure Limited	7.44	$ 725.388 Millions	$ 97.525 Millions
Intuitive Surgical Inc	7.44	$ 12,115.600 Millions	$ 1,629.350 Millions
Quest Diagnostics Inc	7.43	$ 11,841.000 Millions	$ 1,593.250 Millions
Travere Therapeutics Inc	7.32	$ 651.034 Millions	$ 88.900 Millions
Si bone inc	7.19	$ 222.189 Millions	$ 30.881 Millions
Aurinia Pharmaceuticals Inc	7.18	$ 321.738 Millions	$ 44.795 Millions
Beta Bionics Inc	7.15	$ 127.899 Millions	$ 17.897 Millions
Tarsus Pharmaceuticals Inc	7.15	$ 682.203 Millions	$ 95.466 Millions
Angiodynamics Inc	7.13	$ 323.784 Millions	$ 45.418 Millions
Stryker Corp	6.99	$ 26,300.000 Millions	$ 3,761.500 Millions
Boston Scientific Corporation	6.96	$ 21,070.000 Millions	$ 3,028.750 Millions
Syndax Pharmaceuticals Inc	6.89	$ 289.431 Millions	$ 42.011 Millions
Hca Healthcare Inc	6.85	$ 78,701.000 Millions	$ 11,495.250 Millions
Ceribell Inc	6.77	$ 109.203 Millions	$ 16.138 Millions
Medpace Holdings Inc	6.73	$ 2,838.385 Millions	$ 421.525 Millions
Carlisle Companies Incorporated	6.67	$ 5,213.500 Millions	$ 781.625 Millions
Iradimed Corporation	6.62	$ 89.340 Millions	$ 13.487 Millions
3m Company	6.59	$ 25,247.000 Millions	$ 3,832.500 Millions

Date modified: 2026-11-06T13:03:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.